ResMed Inc Stock Forecast for 2023 - 2025 - 2030
Updated on 04/26/2024
ResMed Inc Stock Forecast and Price Target
Given the average yearlong price target of $205.00 provided by seven prominent analysts over the past few months, there is a potential upside of approximately 11.77% from the last closing price in April, 2024 for ResMed Inc's stock if it is reached. This estimation is based on a high estimate of $258.00 and a low estimate of $180.00. If you're looking for information on ResMed Inc stock, consider checking out the forecasts for comparable firms such as NasdaqGS:ISRG.
11.77% Upside
ResMed Inc Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, ResMed Inc's Price has decreased by 100.00%, going from $168.79 to $0.00. In the next year, analysts predict that Fair Value will reach $276.94 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$106.86 | Buy/Sell | $118.92 | 18.38% |
| ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$373.12 | Buy/Sell | $408.45 | 15.24% |
| BSX Stock Forecast | Boston Scientific | Outperform |
11
|
$73.26 | Buy/Sell | $70.14 | 9.20% |
| DXCM Stock Forecast | DexCom Inc | Buy |
12
|
$138.01 | Buy/Sell | $125.98 | 8.69% |
| VAR Stock Forecast | Varian Medical Systems | - |
16
|
$176.53 | Buy/Sell | $177.67 | -100.00% |
ResMed Inc Revenue Forecast for 2023 - 2025 - 2030
ResMed Inc's Revenue has grown in the last three years, jumping from $2.96B to $4.22B – an increase of 42.81%. In the next year, analysts predict that Revenue will reach $4.42B – an increase of 4.72%. For the next seven years, the forecast is for Revenue to grow by 72.37%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SWAV Stock Forecast | Shockwave Medical | Hold |
4
|
$328.99 | Buy/Sell | $239.91 | 1.83% |
| PODD Stock Forecast | Insulet | Outperform |
15
|
$164.17 | Buy/Sell | $222.05 | 43.75% |
| LVGO Stock Forecast | Livongo Health | - |
0
|
$0.00 | Buy/Sell | $126.17 | 0.00% |
.jpg)
ResMed Inc Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, ResMed Inc's Dividend per Share has increased by 12.82%, going from $1.56 to $1.76. In the next year, analysts are expecting an increase in Dividend per Share, predicting it will reach $2.02 – an increase of 14.77%. The ResMed Inc forecast is for Dividend per Share to reach $3.14 or grow by 78.27%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MASI Stock Forecast | Masimo | Outperform |
14
|
$135.24 | Buy/Sell | $96.33 | 16.90% |
| INSP Stock Forecast | Inspire Medical Systems | Outperform |
6
|
$231.01 | Buy/Sell | $225.45 | 14.71% |
| ITGR Stock Forecast | Integer Holdings | Outperform |
16
|
$111.15 | Buy/Sell | $95.00 | 16.96% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| AXNX Stock Forecast | Axonics | Hold |
7
|
$66.54 | Buy/Sell | $70.15 | 6.70% |
| CMD Stock Forecast | Cantel Medical LLC | - |
17
|
$0.05 | Buy/Sell | $85.00 | -100.00% |
| IRTC Stock Forecast | iRhythm Technologies | Buy |
11
|
$111.27 | Buy/Sell | $126.70 | 21.33% |
ResMed Inc EBITDA Forecast for 2023 - 2025 - 2030
ResMed Inc's EBITDA has increased by 40.01% In the last three years, going from $922.89M to $1.29B. In the next year, analysts expect EBITDA to reach $1.53B – an increase of 18.41%. For the next seven years, the forecast is for EBITDA to grow by 97.89%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TMDX Stock Forecast | TransMedics Group | Outperform |
8
|
$89.25 | Buy/Sell | $90.00 | 13.17% |
| TNDM Stock Forecast | Tandem Diabetes Care | Outperform |
9
|
$35.56 | Buy/Sell | $30.80 | 2.64% |
| CNMD Stock Forecast | CONMED | Outperform |
16
|
$61.90 | Buy/Sell | $123.38 | 39.74% |
ResMed Inc EBIT Forecast for 2023 - 2025 - 2030
In the last three years, ResMed Inc's EBIT has grown, increasing from $809.06M to $1.15B – a growth of 42.39%. The next year looks promising for ResMed Inc, with analysts predicting EBIT of $1.35B – an increase of 17.53%. Over the next seven years, experts anticipate that ResMed Inc's EBIT will grow at a rate of 94.36%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| GNMK Stock Forecast | GenMark Diagnostics | - |
2
|
$0.00 | Buy/Sell | $24.05 | 0.00% |
| NTUS Stock Forecast | Natus Medical | - |
14
|
$32.96 | Buy/Sell | $36.00 | 16.60% |
| QTRX Stock Forecast | Quanterix | Outperform |
11
|
$15.59 | Buy/Sell | $32.00 | 105.26% |
ResMed Inc EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, ResMed Inc's EPS has decreased by 100.00%, going from $4.76 to $0.00. In the next year, analysts predict that EPS will reach $7.81 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SLNO Stock Forecast | Soleno Therapeutics | Buy |
0
|
$47.32 | Buy/Sell | $6.00 | 7.78% |
| SILK Stock Forecast | Silk Road Medical, Inc | Outperform |
7
|
$17.65 | Buy/Sell | $12.33 | 7.65% |
| NVRO Stock Forecast | Nevro | Hold |
6
|
$11.62 | Buy/Sell | $21.34 | 37.69% |
.jpg)